Key Takeaways for Clinicians: Understanding the Delay and Its Implications On February 14, 2025, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) announced a delay in implementing the final rule concerning telemedicine prescribing of buprenorphine. Originally set to take effect on February 18, the new effective date is now […]